Eli Lilly’s experimental coronavirus therapy, bamlanivimab, received an emergency use authorization for mild to moderate COVID-19.
from BuzzFeed News https://ift.tt/3n91AyG
Post Page Advertisement [Top]
Subscribe to:
Post Comments (Atom)
Bottom Ad [Post Page]
No comments:
Post a Comment